Aodh Lifesciences is a unique biopharmaceutical company with a mission to treat acute and chronic respiratory tract disorders associated with serious complications and devastating effects on patients quality of life.
Unlike currently available treatments for antibiotics and viral infections or respiratory tract and lung tree, our innovative approach provides targeted delivery to the pulmonary so that infections can be treated with minimal unwanted systemic effects. The Aodh Lifesciences team has an extensive track record in the development of novel inhaled medicines for respiratory indications. The team has particular expertise in the identification of compounds with optimal characteristics for lung delivery.
Aodh Lifesciences developed more efficient drug delivery systems capable of delivering sufficient doses and finer particles into the lung. As more efficient pulmonary delivery devices and sophisticated formulations become available, physicians and health professionals will have a choice of a wide variety of device and formulation combinations that will target specific cells or regions of the lung, avoid the lung's clearance mechanisms and be retained within the lung for longer periods.
We are expanding our toolbox of drug modalities beyond the more traditional delivery system, to allow us to target in the body that were previously seen as hard-to-reach.